IBERDOMIDE

IBERDOMIDE was reported 149 times

IBERDOMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RETINAL COLLATERAL VESSELS 1 0.2000
1 PARAINFLUENZA VIRUS INFECTION 5 0.0485
2 MENINGOENCEPHALITIS BACTERIAL 1 0.0068
3 PITYRIASIS RUBRA PILARIS 1 0.0042
4 LISTERIA SEPSIS 1 0.0038
5 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
6 DEVICE RELATED BACTERAEMIA 1 0.0032
7 EUTHANASIA 1 0.0032
8 MENINGITIS PNEUMOCOCCAL 1 0.0027
9 BRONCHOPNEUMOPATHY 1 0.0027
10 HERPES SIMPLEX REACTIVATION 1 0.0026
11 MIXED LIVER INJURY 7 0.0023
12 ANASTOMOTIC ULCER 1 0.0022
13 BILIARY SEPSIS 1 0.0022
14 LISTERIOSIS 2 0.0018
15 RECTAL ADENOCARCINOMA 1 0.0017
16 NEURODEGENERATIVE DISORDER 1 0.0016
17 CYTOMEGALOVIRUS CHORIORETINITIS 3 0.0015
18 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 1 0.0012
19 PHLEBITIS 6 0.0012
20 VASCULAR DEMENTIA 1 0.0011
21 KLEBSIELLA BACTERAEMIA 1 0.0011
22 CEREBELLAR ATAXIA 1 0.0010
23 AUTONOMIC NEUROPATHY 1 0.0010
24 STEROID WITHDRAWAL SYNDROME 1 0.0010
25 INTRADUCTAL PROLIFERATIVE BREAST LESION 1 0.0008
26 PLASMA CELL MYELOMA REFRACTORY 1 0.0007
27 INFECTIOUS PLEURAL EFFUSION 1 0.0007
28 KERATOPATHY 1 0.0006
29 NEUTROPENIC SEPSIS 4 0.0006
30 MONOPARESIS 1 0.0006
31 ADENOCARCINOMA OF COLON 1 0.0005
32 CELL DEATH 1 0.0005
33 RENAL COLIC 1 0.0004
34 COVID-19 PNEUMONIA 5 0.0004
35 LIPOMA 1 0.0004
36 CHOLECYSTITIS ACUTE 2 0.0004
37 HAEMATOLOGICAL MALIGNANCY 1 0.0004
38 FEBRILE NEUTROPENIA 22 0.0003
39 BRAIN DEATH 1 0.0003
40 ACUTE MYELOID LEUKAEMIA 4 0.0003
41 PLASMA CELL MYELOMA 10 0.0003
42 SKIN PAPILLOMA 1 0.0002
43 BONE MARROW FAILURE 5 0.0002
44 CYTOPENIA 3 0.0002
45 HYPERURICAEMIA 1 0.0002
46 PSEUDOMONAS INFECTION 2 0.0002
47 ILEUS PARALYTIC 1 0.0002
48 LUMBAR VERTEBRAL FRACTURE 1 0.0002
49 MYELODYSPLASTIC SYNDROME 3 0.0002
50 MUCOSAL INFLAMMATION 5 0.0002
51 ANAL FISTULA 1 0.0002
52 ANAL ABSCESS 1 0.0002
53 HYPERKERATOSIS 1 0.0002
54 SKIN TOXICITY 1 0.0002
55 HERPES VIRUS INFECTION 1 0.0002
56 HYPERCALCAEMIA 2 0.0002
57 INCOHERENT 1 0.0002
58 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
59 LYMPHOEDEMA 1 0.0001
60 LYMPHOPENIA 2 0.0001
61 NEUTROPENIA 19 0.0001
62 ARTHROPOD BITE 1 0.0001
63 HYPERTHERMIA 1 0.0001
64 FURUNCLE 1 0.0001
65 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
66 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
67 GASTROINTESTINAL INFECTION 1 0.0001
68 UROSEPSIS 1 0.0001
69 THROMBOCYTOPENIA 12 0.0001
70 ERYTHEMA MULTIFORME 1 0.0001
71 DIARRHOEA HAEMORRHAGIC 1 0.0001
72 AUTOIMMUNE DISORDER 1 0.0001
73 VITAMIN D DEFICIENCY 1 0.0001
74 LEUKOPENIA 5 0.0001
75 PNEUMOCYSTIS JIROVECII PNEUMONIA 1 0.0001
76 BODY TEMPERATURE INCREASED 2 0.0001
77 EYE DISCHARGE 1 0.0001
78 SKIN INFECTION 1 0.0001
79 SCAB 1 0.0001
80 BURSITIS 1 0.0001
81 HEPATIC CYTOLYSIS 1 0.0001
82 HIATUS HERNIA 1 0.0001
83 INFUSION RELATED REACTION 5 0.0001
84 ADVERSE REACTION 1 0.0001
85 SKIN LESION 2 0.0001
86 HYPOMAGNESAEMIA 1 0.0001
87 HIP ARTHROPLASTY 1 0.0001
88 THERAPY PARTIAL RESPONDER 1 0.0001
89 BASAL CELL CARCINOMA 1 0.0001
90 COVID-19 11 0.0001
91 HYPERKALAEMIA 2 0.0001
92 LYMPHADENOPATHY 2 0.0001
93 ISCHAEMIC STROKE 1 0.0001
94 INFECTION 8 0.0001
95 SEPSIS 6 0.0001
96 CHOLESTASIS 1 0.0001
97 ACUTE RESPIRATORY FAILURE 1 0.0001
98 CYTOKINE RELEASE SYNDROME 1 0.0000
99 PANCREATITIS ACUTE 1 0.0000
100 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
101 NEUROPATHY PERIPHERAL 4 0.0000
102 PRESYNCOPE 1 0.0000
103 PNEUMONIA 13 0.0000
104 CELLULITIS 2 0.0000
105 RESPIRATORY TRACT INFECTION 1 0.0000
106 RESPIRATORY DISTRESS 1 0.0000
107 MENTAL STATUS CHANGES 1 0.0000
108 ANGINA PECTORIS 1 0.0000
109 HYPERSOMNIA 1 0.0000
110 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
111 EPILEPSY 1 0.0000
112 ANAEMIA 6 0.0000
113 EYE DISORDER 1 0.0000
114 INFLUENZA 3 0.0000
115 INTESTINAL OBSTRUCTION 1 0.0000
116 COLITIS 1 0.0000
117 NEUTROPHIL COUNT DECREASED 1 0.0000
118 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
119 THERAPY NON-RESPONDER 1 0.0000
120 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
121 PRODUCTIVE COUGH 1 0.0000
122 LUNG DISORDER 1 0.0000
123 SYNCOPE 2 0.0000
124 HYPOTENSION 4 0.0000
125 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
126 DISTURBANCE IN ATTENTION 1 0.0000
127 BLISTER 1 0.0000
128 URINARY TRACT INFECTION 3 0.0000
129 BONE PAIN 1 0.0000
130 CHILLS 2 0.0000
131 NASAL CONGESTION 1 0.0000
132 DISEASE PROGRESSION 2 0.0000
133 STOMATITIS 1 0.0000
134 RASH 7 0.0000
135 DEEP VEIN THROMBOSIS 1 0.0000
136 SWELLING FACE 1 0.0000
137 BLOOD CREATININE INCREASED 1 0.0000
138 NEOPLASM MALIGNANT 1 0.0000
139 INJURY 1 0.0000
140 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
141 RESPIRATORY FAILURE 1 0.0000
142 ACUTE KIDNEY INJURY 2 0.0000
143 CARDIAC FAILURE CONGESTIVE 1 0.0000
144 PROSTATE CANCER 1 0.0000
145 GASTROINTESTINAL DISORDER 1 0.0000
146 CARDIAC DISORDER 1 0.0000
147 SWELLING 1 0.0000
148 PULMONARY EMBOLISM 1 0.0000
149 ATRIAL FIBRILLATION 1 0.0000
150 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
151 FATIGUE 7 0.0000
152 MUSCULAR WEAKNESS 1 0.0000
153 PRURITUS 3 0.0000
154 RENAL FAILURE 1 0.0000
155 VISION BLURRED 1 0.0000
156 MEMORY IMPAIRMENT 1 0.0000
157 TOXICITY TO VARIOUS AGENTS 1 0.0000
158 MYALGIA 1 0.0000
159 MYOCARDIAL INFARCTION 1 0.0000
160 OFF LABEL USE 5 0.0000
161 MUSCLE SPASMS 1 0.0000
162 PRODUCT USE ISSUE 1 0.0000
163 ASTHENIA 2 0.0000
164 ABDOMINAL PAIN UPPER 1 0.0000
165 ARTHRALGIA 2 0.0000
166 DIARRHOEA 3 0.0000
167 BACK PAIN 1 0.0000
168 ANXIETY 1 0.0000
169 DEATH 3 0.0000
170 PYREXIA 1 0.0000
171 NAUSEA 2 0.0000
172 VOMITING 1 0.0000
173 DIZZINESS 1 0.0000
174 DYSPNOEA 1 0.0000
175 HEADACHE 1 0.0000
176 DRUG INEFFECTIVE 2 0.0000